EP2952191
Apómorfín undir tungu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.6.2010EP published:
22.8.2018EP application number:
15175258.1
EP translation filed:
21.11.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
10.6.2030Expiry date:
10.6.2026Next due date:
30.6.2026
Title:
SUBLINGUAL APOMORPHINE
Timeline
Today
11.6.2010EP application
22.8.2018EP Publication
21.11.2018Translation submitted
15.12.2018Registration published
10.6.2026Expires
Owner
Name:
Sumitomo Pharma America, Inc.Address:
84 Waterford Drive, Marlborough, MA 01752, US
Inventor
Name:
Giovinazzo, Anthony JohnAddress:
Oakville, Ontario L6H 0B9, CA
Name:
Hedden, David BruceAddress:
Ann Arbor, MI, US
Name:
de Somer, Marc L.Address:
Winchester, Massachusetts, US
Name:
Bryson, Nathan JohnAddress:
Toronto, Ontario M4W 2V8, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
186445 PDate:
12.6.2009Country:
US
Classification
Categories:
A61K 31/473, A61K 31/44, A01N 43/42, A61K 47/02, A61P 15/10, A61P 25/16
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 20.5.2019
Expires: 10.6.2020
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 19.5.2020
Expires: 10.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.5.2021
Expires: 10.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 18.5.2022
Expires: 10.6.2023
Payer: Patice ehf.
Number: 14
Paid: 24.5.2023
Expires: 10.6.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 21.5.2024
Expires: 10.6.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 4.6.2025
Expires: 10.6.2026
Payer: Árnason Faktor ehf.